Skip to content
Myeloma Minute Survey
1.
Do you generally read the Myeloma Minute e-newsletter on
Phone
Laptop/Desktop
Tablet
2.
What topics in the Myeloma Minute newsletter are most interesting to you? (Choose up to 3)
Dr. Brian G.M. Durie’s weekly blog
FDA drug approval news
Event registration details for IMF Patient & Family Seminars or Regional Community Workshops
Event registration details for M-Power Project Workshops
RSVP information for Facebook Live Events
Details about Spanish-language events such as Las Voces de Mieloma
Information about upcoming IMF fundraising events, such as Miles for Myeloma or Laughs for Life
Educational videos such as Ask Dr. Durie or Myeloma Made Simple
Podcasts such as “A Day in the Life” or “Myeloma Voices” with myeloma patients and care partners
Advocacy initiatives, such as advocating for oral parity legislation or learning about the Global Myeloma Action Network’s recent developments
International myeloma research news
Reports from the American Society of Hematology (ASH) or American Society of Clinical Oncology (ASCO) annual meetings
IMF Myeloma Awareness initiatives such as Myeloma ACTION Month and Blood Cancer Awareness Month
Details about the IMF’s most recent publications such as Myeloma Today or the Understanding series of booklets
Details about upcoming Support Group meetings and IMF support activities
Organizational updates and press releases
3.
What topics would you like to see covered more in the Myeloma Minute? (Choose up to 3)
Dr. Brian G.M. Durie’s weekly blog
FDA drug approval news
Event registration details for IMF Patient & Family Seminars or Regional Community Workshops
Event registration details for M-Power Project Workshops
RSVP information for Facebook Live Events
Details about Spanish-language events such as Las Voces de Mieloma
Information about upcoming IMF fundraising events, such as Miles for Myeloma or Laughs for Life
Educational videos such as Ask Dr. Durie or Myeloma Made Simple
Podcasts such as “A Day in the Life” or “Myeloma Voices” with myeloma patients and care partners
Advocacy initiatives, such as advocating for oral parity legislation or learning about the Global Myeloma Action Network’s recent developments
International myeloma research news
Reports from the American Society of Hematology (ASH) or American Society of Clinical Oncology (ASCO) annual meetings
IMF Myeloma Awareness initiatives such as Myeloma ACTION Month and Blood Cancer Awareness Month
Details about the IMF’s most recent publications such as Myeloma Today or the Understanding series of booklets
Details about upcoming Support Group meetings and IMF support activities
Organizational updates and press releases
4.
What topics in the Myeloma Minute do you find to be the least relevant/interesting? (Choose up to 3)
Dr. Brian G.M. Durie’s weekly blog
FDA drug approval news
Event registration details for IMF Patient & Family Seminars or Regional Community Workshops
Event registration details for M-Power Project Workshops
RSVP information for Facebook Live Events
Details about Spanish-language events such as Las Voces de Mieloma
Information about upcoming IMF fundraising events, such as Miles for Myeloma or Laughs for Life
Educational videos such as Ask Dr. Durie or Myeloma Made Simple
Podcasts such as “A Day in the Life” or “Myeloma Voices” with myeloma patients and care partners
Advocacy initiatives, such as advocating for oral parity legislation or learning about the Global Myeloma Action Network’s recent developments
International myeloma research news
Reports from the American Society of Hematology (ASH) or American Society of Clinical Oncology (ASCO) annual meetings
IMF Myeloma Awareness initiatives such as Myeloma ACTION Month and Blood Cancer Awareness Month
Details about the IMF’s most recent publications such as Myeloma Today or the Understanding series of booklets
Details about upcoming Support Group meetings and IMF support activities
Organizational updates and press releases
5.
If you have any other feedback on the Myeloma Minute weekly e-newsletter, please feel free to write it in this box.
